CONRAD, a reproductive health research organization, announced today that it has halted a Phase III clinical trial of cellulose sulfate - a topical microbicide gel being tested for HIV prevention in women - because preliminary results indicated that cellulose sulfate could lead to an increased risk of HIV infection in women who use the compound. The trial was being conducted in South Africa, Benin, Uganda, and India.
Read the full story
